However, the proportion of patients with high NT-proBNP was greater than that of patients experiencing HHF during follow-up; the canaglifozin-mediated decrease in NT-proBNP explained only a small portion of the effects of canaglifozin in decreasing HF events. The gene discussed is NPPB; the disease is hydrops fetalis.